360° SearchNetwork Hot Spots Trends Time Series

Delcath Systems Incorporated

Type: Company

Name: Delcath Systems Incorporated

First reported 1 hour ago - Updated 1 hour ago - 1 reports

INVESTOR NOTICE: The Rosen Law Firm Announces Securities Fraud Class Action Against Delcath Systems, Inc. - DCTH

NEW YORK--(BUSINESS WIRE)-- The Rosen Law Firm today announced that a class action lawsuit has been filed on behalf of investors who purchased the securities of Delcath Systems, Inc. (Nasdaq: DCTH) during the period from April 21, 2010 through May 2, ... [Published Investors Business Daily - 1 hour ago]

Entities: Rosen Law Firm P A, Delcath Systems Incorporated, Class Action

First reported May 18 2013 - Updated May 18 2013 - 1 reports

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Delcath Systems, Inc. To..

NEW YORK (Logo:$ http://photos.prnewswire.com/prnh/20120119/MM38856LOGO)The investigation focuses on whether the Company and its executives violated federal securities laws by failing to disclose that: $ (1) the Company's New Drug Application ("NDA") ... [Published ADVFN UK - May 18 2013]

Entities: FARUQI & FARUQI, Delcath Systems Incorporated, ocular melanoma, New Drug Application, Metastatic

First reported May 17 2013 - Updated May 17 2013 - 1 reports

Form 8-K DELCATH SYSTEMS, INC. For: May 16

StreetInsider.com - Form 8-K DELCATH SYSTEMS, INC. For: May 16 ... [Published Street Insider - May 17 2013]

Entities: Delcath Systems Incorporated, 8-k

First reported May 17 2013 - Updated May 17 2013 - 1 reports

Delcath facing lawsuits in wake of stock drop

A Maryland law firm is seeking a Delcath Systems Inc. investor to act as the lead plaintiff in a class action suit against the medical device manufacturer.Brower Piven P.C. of Stevensen, Md., has issued an alert urging investors who lost more than $250,000 ... [Published New York Business Journal - May 17 2013]

Entities: Lawsuit, Delcath Systems Incorporated, Class Action, Medical Devices

First reported May 17 2013 - Updated May 17 2013 - 1 reports

Wright Medical Group Inc

Wright Medical Group Elects Douglas Watson to Board of Directors

Wright Medical Group, Inc. announced that its shareholders have approved a proposal increasing the size of Wright's Board of Directors to ten and have elected Douglas Watson as Wright Medical's tenth Director, effective immediately. According to a release, ... [Published Individual.com - May 17 2013]

Entities: Wright Medical Group Inc, BioMimetic Therapeutics Inc, Ciba Pharmaceuticals Co, Javelin Pharmaceuticals Inc, Bionor Immuno AS

First reported May 14 2013 - Updated May 14 2013 - 1 reports

Delcath Systems has the Lowest Sales per Share in the Health Care Equipment Industry (DCTH, ETRM, MELA, BSDM, CRDC)

(Comtex SmarTrend(R)) Below are the three companies in the Health Care Equipment industry with the lowest sales per share. Sales per share is a valuable metric in comparing relative value for companies in the same industry.Delcath Systems ranks lowest ... [Published Individual.com - May 14 2013]

Entities: Delcath Systems Incorporated, Health Care, Comtex

First reported May 13 2013 - Updated May 13 2013 - 1 reports

Delcath Systems, Inc. (NASDAQ:DCTH) Investor Alert: Lawsuit Alleges Misleading Statements

A lawsuit was filed for certain investors in shares of Delcath Systems, Inc. (NASDAQ:DCTH) over alleged securities laws violations by Delcath Systems, Inc. Deadline: July 8, 2013. NASDAQ:DCTH investors should contact the Shareholders Foundation at ma ... [Published SBWire - May 13 2013]

Entities: Delcath Systems Incorporated, Stocks, Lawsuit, ocular melanoma, current Good Manufacturing Practices

First reported May 03 2013 - Updated May 03 2013 - 6 reports

UPDATE 4: Friday's movers: Regeneron, LinkedIn

SAN FRANCISCO (MarketWatch) -- Shares of Regeneron Pharmaceuticals Inc. led gains in the S&P 500 on Friday while LinkedIn Corp. and Delcath Systems shares fell. LinkedIn and InvenSense Inc. dominated investor attention.GainersShares of Regeneron (REGN) ... [Published TD Ameritrade - May 03 2013]

Entities: Regeneron, LinkedIn Corp, InvenSense Inc, Delcath Systems Incorporated

First reported May 02 2013 - Updated May 03 2013 - 5 reports

DELCATH PROVIDES UPDATE ON FDA ADVISORY COMMITTEE MEETING ON MELBLEZTM KIT Thomson Reuters ONE

$ DELCATH PROVIDES UPDATE ON FDA ADVISORY COMMITTEE MEETING ON MELBLEZTM KITQueensbury, NY - May 2, 2013 - Delcath Systems, Inc. (DCTH) today announced that the U.S. Food and Drug Administration`s (FDA) Oncologic Drugs Advisory Committee (ODAC) voted ... [Published Yahoo! Finance - May 02 2013]

Entities: melphalan, New Drug Application, hepatic, Metastatic

First reported May 02 2013 - Updated May 03 2013 - 5 reports

Delcath's Cancer Therapy Gets Disapproval from FDA Advisers

A panel of advisers to the U. S. health regulator unanimously recommended Delcath Systems Inc.'s cancer therapy to be risky. FDA advisers unanimously disapproved the therapy for a rare form of eye cancer that is known to spread to the liver.There was ... [Published TopNews United States - May 03 2013]

Entities: FDA Food & Drug Administration, Advisers, Cancer

First reported May 03 2013 - Updated May 03 2013 - 3 reports

Delcath Systems Lowered to “Underperform” at Cowen (DCTH)

A number of other analysts have also recently weighed in on DCTH. Analysts at Wedbush downgraded shares of Delcath Systems from an "outperform" rating to a "neutral" rating in a research note to investors on Friday. Separately, analysts at Roth Capital ... [Published American Banking News - Stock Ratings - May 03 2013]

Entities: Delcath Systems Incorporated, Roth Capital Partners, Investment Analysts

First reported Apr 30 2013 - Updated May 01 2013 - 11 reports

DELCATH SYSTEMS, INC.: Delcath to report first quarter 2013 results on may 8, 2013

Company to Provide Update on ODAC Panel MeetingQUEENSBURY,NY-May 1,2013 - Delcath Systems, Inc. (NASDAQ: DCTH) today announced that it will host a conference call and webcast on Wednesday, May 8, 2013 at 4:30 p.m. ET to discuss the Company's financial ... [Published 4 Traders - May 01 2013]

Entities: melphalan, Delcath Systems Incorporated, FDA Food & Drug Administration, hepatic, doxorubicin

Quotes

...On February 22, 2011, the Company disclosed that it had received a "refusal to file" letter from the U S Food & Drug Administration ("FDA ") for its NDA for its proprietary chemosaturation system. The letter "requested information involving manufacturing plant inspection timing, product and sterilization validations and additional safety information [...] as well as additional statistical analysis clarification." On this news, Delcath shares plummeted $4.29 or 38%, to close at $7.01 per share."

INVESTOR NOTICE: The Rosen Law Firm Announces Securities Fraud Class Action Against Delcath Syste ... [Published Investors Business Daily - 1 hour ago]

...The letter "requested information involving manufacturing plant inspection timing, product and sterilization validations and additional safety information [...] as well as additional statistical analysis clarification." On this news, Delcath shares plummeted $4.29 or 38%, to close at $7.01 per share

INVESTOR NOTICE: The Rosen Law Firm Announces Securities Fraud Class Action Against Delcath Syste ... [Published Business Wire - 2 hours ago]

...Doug's proven leadership skills and extensive operational expertise join our board," said David Stevens, chairman of the board of Wright Medical. "As a past director of BioMimetic Therapeutics, Doug brings to our Board of Directors an institutional knowledge of BioMimetic's products and operations that will be of great value as the company's management team continues to execute its transformational plan, as well as our strategy of building a world-class biologics platform and accelerating growth in our foot and ankle business."

Wright Medical Group Elects Douglas Watson to Board of Directors [Published Individual.com - May 17 2013]

Shareholder rights attorney Willie Briscoe said, "Recent revelations about alleged improper business practices and procedures regarding key aspects of Delcath’s business and other misleading financial statements have prompted the firms to investigate possible breaches of fiduciary duties and other violations of state law by Delcath’s officers and directors. Based on our investigation, we are prepared to pursue litigation to preserve the company and the value of Delcath stock for all shareholders." is a full service business litigation, commercial transaction, and public advocacy firm with more than 20 years of experience in complex litigation and...

Delcath Systems Shareholder Alert: Briscoe Law and Powers Taylor Investigate Possible Breaches of ... [Published Business Wire - May 10 2013]

More Content

sort by: Date \| Relevance
INVESTOR NOTICE: The Rosen Law Firm Announces S... [Published Investors Business Daily - 1 hour ago]
Glancy Binkow & Goldberg LLP Announces Class Ac... [Published Business Wire - 2 hours ago]
INVESTOR NOTICE: The Rosen Law Firm Announces S... [Published Business Wire - 2 hours ago]
Glancy Binkow & Goldberg LLP Announces Class Ac... [Published Business Wire Professional Services News - 2 hours ago]
INVESTOR NOTICE: The Rosen Law Firm Announces S... [Published Business Wire Professional Services News - 2 hours ago]
Faruqi & Faruqi, LLP Encourages Investors Who S... [Published ADVFN UK - May 18 2013]
Faruqi & Faruqi, LLP Encourages Investors Who S... [Published PR Newswire: Financial Services - May 18 2013]
Pomerantz Law Firm Reminds Shareholders With Lo... [Published GlobeNewswire: Acquisitions News - May 17 2013]
Form 8-K DELCATH SYSTEMS, INC. For: May 16 [Published Street Insider - May 17 2013]
Delcath facing lawsuits in wake of stock drop [Published New York Business Journal - May 17 2013]
Delcath Systems, Inc. (DCTH) - Product Pipeline... [Published MarketResearch.com - May 17 2013]
Wright Medical Group Elects Douglas Watson to B... [Published Individual.com - May 17 2013]
Wright Medical Group, Inc. Appoints Douglas G. ... [Published Yahoo! Finance - May 14 2013]
Wright Medical Group, Inc. Appoints Douglas G. ... [Published NewsBlaze - May 14 2013]
Delcath Systems has the Lowest Sales per Share ... [Published Individual.com - May 14 2013]
Delcath Systems, Inc. (NASDAQ:DCTH) Investor Al... [Published SBWire - May 13 2013]
SHAREHOLDER ALERT: Brower Piven Encourages Inve... [Published Interest!ALERT - May 11 2013]
SHAREHOLDER ALERT: Brower Piven Encourages Inve... [Published GlobeNewswire: Acquisitions News - May 11 2013]
Additional Lots Added: Voluntary Nationwide Rec... [Published NewsBlaze - May 11 2013]
Delcath Systems, Inc. Sued by Investor [Published ADVFN UK - May 11 2013]
Delcath Systems, Inc. Sued by Investor [Published Financial Services - May 11 2013]
Delcath Systems Shareholder Alert: Briscoe Law ... [Published NewsBlaze - May 10 2013]
Delcath Systems Shareholder Alert: Briscoe Law ... [Published Business Wire - May 10 2013]
Delcath Systems Shareholder Alert: Briscoe Law ... [Published Business Wire Professional Services News - May 10 2013]
Federman & Sherwood Announces That a Securities... [Published Stockwatch - May 10 2013]
Federman & Sherwood Announces That a Securities... [Published Marketwire - Breaking News Releases - May 10 2013]
Stocks Showing Significant Fall (LPSN, GSS, ARI... [Published SBWire - May 10 2013]
News Recap (LivePerson, Orthofix International ... [Published SBWire - May 10 2013]
Today's Research on DCTH, AKRX, ASTX, BMRN, and... [Published Individual.com - May 10 2013]
CRZO, DCTH, BXC, DAL, ONSM, INO Are Seasonally ... [Published PredictWallStreet - May 10 2013]

Blogs

sort by: Date \| Relevance
This is What Happened With Delcath [Published EquityJungle - v0.1 - May 01 2013] Shares of Delcath Systems Inc. (Nasdaq: DCTH) fell more than 40% yesterday after U.S. Food and Drug Administration (FDA) staffers said the company's experimental liver-cancer-treatment system would probably require anot... ...
Oracle Releases Secure Global Desktop and 2 Mor... [Published Wall St. Cheat Sheet - Apr 30 2013] Oracle Corporation ( NASDAQ:ORCL ): Current price $32.76On Tuesday, Oracle announced its new release of Oracle Secure Global Desktop, forming part of Oracle’s Desktop Virtualization portfolio. Oracle Secure Global Desktop 5.0 extends secure, anywhere-access ...
Oracle Releases Secure Global Desktop and 2 Mor... [Published Wall St. Cheat Sheet - Apr 30 2013] Oracle Corporation ( NASDAQ:ORCL ): Current price $32.76 On Tuesday, Oracle announced its new release of Oracle Secure Global Desktop, forming part of Oracle’s Desktop Virtualization portfolio. Oracle Secure Global Desktop 5.0 extends secure, anywhere-access ...
Upcoming FDA Advisory Committee Meetings and To... [Published Eye on FDA - Mar 28 2013] In January Eye on FDA ran a look at the upcoming advisory committee meetings and their topics and it is time for an update. It turns out that April is a ridiculously busy AdComm month, but there are some interesting meetings certainly. April ...
4 Healthcare Stock Stories to Keep Investors Well [Published Wall St. Cheat Sheet - Feb 27 2013] Accretive Health ( NYSE:AH ) Current price $9.40 The firm said Tuesday it will delay posting its financial results for the fourth quarter and full year 2012, along with its previously announced investor conference call set for February 27th, because ...

Press Releases

sort by: Date \| Relevance
Glancy Binkow & Goldberg LLP Announces Class Ac... [Published Business Wire - 2 hours ago]
INVESTOR NOTICE: The Rosen Law Firm Announces S... [Published Business Wire - 2 hours ago]
Glancy Binkow & Goldberg LLP Announces Class Ac... [Published Business Wire Professional Services News - 2 hours ago]
INVESTOR NOTICE: The Rosen Law Firm Announces S... [Published Business Wire Professional Services News - 2 hours ago]
Faruqi & Faruqi, LLP Encourages Investors Who S... [Published PR Newswire: Financial Services - May 18 2013]